AccessPak for HIV PEP Expanded with Kaletra and Conjugated estrogens vaginal
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Conjugated estrogens vaginal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: conjugated estrogens topical
Brand name: Premarin Vaginal, Synthetic Conjugated Estrogens, A, Premarin Vaginal Cream, Synthetic Conjugated Estrogens-A
Synonyms: Conjugated estrogens (vaginal), Estrogens (Conjugated/Equine, Topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Conray
- AccessPak for HIV PEP Expanded with Kaletra-Conray 30
- AccessPak for HIV PEP Expanded with Kaletra-Conray 400
- AccessPak for HIV PEP Expanded with Kaletra-Conray 43
- AccessPak for HIV PEP Expanded with Kaletra-Consensi
- AccessPak for HIV PEP Expanded with Kaletra-Constulose
- Conjugated estrogens vaginal-AccessPak for HIV PEP Expanded with Viracept
- Conjugated estrogens vaginal-Accolate
- Conjugated estrogens vaginal-Accretropin
- Conjugated estrogens vaginal-Accucaine
- Conjugated estrogens vaginal-AccuHist Drops
- Conjugated estrogens vaginal-AccuHist PDX Drops